Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ACE2 enhance viral infection or viral infection aggravate the underlying diseases

Computational and Structural Biotechnology Journal(2020)10.1016/j.csbj.2020.08.002Source: DataRank Database

ACE2 enhance viral infection or viral infection aggravate the underlying diseases is a research paper published in Computational and Structural Biotechnology Journal (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

refsnp pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.17)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Qiyi Tang ORCID,Shaolei Teng ORCID

Live enrichment

PubMed:32832038 PMC:PMC7409731 OpenAlex:https://openalex.org/W3048171632

NIMHD NIH HHS

Grant: G12 MD007597

NIAID NIH HHS

Grant: SC1 AI112785

NIMHD NIH HHS

Grant: U54 MD007597

NIMHD NIH HHS

Grant: U54 MD007592

NIMHD NIH HHS

Grant: G12 MD007592

National Science Foundation

National Institutes of Health

FWCI

0.17

Citation Percentile

0.6%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-sa

journalhttp://www.csbj.org/article/S200103702030355X/pdf

publisherhttp://www.csbj.org/article/S200103702030355X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S200103702030355X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S200103702030355X?httpAccept=text/plain

publisherhttps://spj.science.org/doi/pdf/10.1016/j.csbj.2020.08.002

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19

Keywords

Coronavirus disease 2019 (COVID-19)Viral infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakVirologyImmunologyDiseaseVirusInternal medicineInfectious disease (medical specialty)OutbreakSingle nucleotide polymorphismHealth DisparityAngiotensin Converting Enzyme 2Snp, Single Nucleotide PolymorphismCvd, Cardiovascular DiseaseRas, Renin-angiotensin SystemUnderlying DiseasesRbd, Receptor Binding DomainPah, Pulmonary Artery HypertensionAcei, Ace InhibitorAce2, Angiotensin Converting Enzyme 2Covid-19, Coronavirus Infectious Disease-19Coronavirus Infectious Disease-19Severe Acute Respiratory Syndrome Coronavirus −2R0, Reproductive NumberS, Spike: Tmprss2, Transmembrane Protease, Serine 2Sars-cov-2, Severe Acute Respiratory Syndrome Coronavirus −2 Sars-cov-2, Middle East Respiratory Syndrome 2: Mers-2

Sustainable Development Goals

SDG 0: Good health and well-being

ACE2 enhance viral infection or viral infection aggravate the underlying diseases

FAIR Checklist

Authors (2)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)